MENU
Services and Programs
Inventor Zone
Entrepreneur Zone
Industry Zone
Investor Zone
SOVAR Process
Portfolio
Life Sciences
Medical Technologies
Science and Engineering
Information Technologies
Clean Technologies
Agribusiness
Social Innovations
Startups and Transfers
Sovar
Who we are
Our approach
Partners
Governance and Boards
Team
Careers
News
Contact
FRANÇAIS
Portfolio
LIFE SCIENCES
Ultrastable mucoadhesive gold nanoparticles for corneal drug delivery
A new biologic approach for treating inflammatory bowel diseases (IBD)
Novel pharmacological combination wound healing
Fusion tag for increasing protein solubility and facilitate purification
Cystamine and analogues for the treatment of Parkinson's disease
DCIR, a new therapeutic target for preventing HIV-1 infection
First irreversible and selective inhibitor of 17β-HSD1 for treatment of breast cancer and endometriosis
